Have a personal or library account? Click to login
Direct oral anticoagulants (DOACs): From the laboratory point of view Cover

Direct oral anticoagulants (DOACs): From the laboratory point of view

Acta Pharmaceutica
Volume 72 (2022): Issue 4 (December 2022)
By: Sandra Margetić,  Sandra Šupraha Goreta,  Ivana Ćelap and  Marija Razum  
Open Access
|Oct 2022

Authors

Sandra Margetić

Department of Clinical Chemistry Sestre milosrdnice, University Hospital Center, Zagreb, Croatia

Sandra Šupraha Goreta

ssupraha@pharma.hr

Department of Biochemistry and Molecular Biology, University of Zagreb Faculty of Pharmacy and Biochemistry, Croatia

Ivana Ćelap

Department of Clinical Chemistry Sestre milosrdnice, University Hospital Center, Zagreb, Croatia

Marija Razum

Department of Clinical Chemistry Sestre milosrdnice, University Hospital Center, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2022-0034 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 459 - 482
Accepted on: Aug 9, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
direct oral anticoagulants ( DOACs),
anticoagulation,
laboratory monitoring
Related subjects:
Pharmacy,
Pharmacy, other

© 2022 Sandra Margetić, Sandra Šupraha Goreta, Ivana Ćelap, Marija Razum, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 72 (2022): Issue 4 (December 2022)Next article